S. 1095

119th Congress

Reported

Stop STALLING Act

Sponsored byDemocrat:Sen. Klobuchar, Amy [D-MN]MN· Introduced 24 March 2025
Open on Congress.gov

6

Cosponsors

6

Actions

0

Amendments

0

Committees

—

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Placed on Senate Legislative Calendar under General Orders. Calendar No. 45.

10 April 2025·1 year ago

Summary

Introduced in Senate · Updated 3 September 2025

Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the Stop STALLING Act

This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.

The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit is subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.

Timeline

6 actions

  1. Placed on Senate Legislative Calendar under General Orders. Calendar No. 45.

    10 April 2025 · Calendars

  2. Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.

    10 April 2025 · Committee

  3. Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.

    10 April 2025 · Committee

  4. Committee on the Judiciary. Ordered to be reported without amendment favorably.

    3 April 2025 · Committee

  5. Read twice and referred to the Committee on the Judiciary.

    24 March 2025 · IntroReferral

  6. Introduced in Senate

    24 March 2025 · IntroReferral

Sponsorship

6 cosponsors

Sponsor

Democrat:Sen. Klobuchar, Amy [D-MN]MN

Cosponsors

  • Democrat467%
  • Republican233%

Classification

Policy area

Health

Legislative subjects

Administrative remediesBusiness ethicsCivil actions and liabilityCompetition and antitrustDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationFood and Drug Administration (FDA)Licensing and registrationsPrescription drugsPublic participation and lobbying
Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.